Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample.

Pharmacogenetics and genomics - 1 Mar 2009

Cabanero Michael, Laje Gonzalo, Detera-Wadleigh Sevilla, McMahon Francis J

Abstract excerpt

A recent study has reported a significant association of variants in phosphodiesterase (PDE) genes with antidepressant treatment outcome in a Mexican American sample. We set out to investigate these findings in a large sample of patients from the Sequenced Treatment Alternatives to Relieve Depres...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3',5'-Cyclic-AMP Phosphodiesterases
Share to 3',5'-Cyclic-GMP Phosphodiesterases
Share to Adolescent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder

Share to Haplotypes

Share to Phosphoric Diester Hydrolases

Share to Psychiatric Status Rating Scales

Source

Open in PubMed Open full text

Identifiers

PMID: 19214142
DOI: 10.1097/FPC.0b013e328320a3e2
PMCID: PMC2819180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19214142-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample.PMID 19214142Read ↗

Genome-wide association studies of antidepressant outcome: a brief review.Semantic proximity Read ↗

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.Semantic proximity Read ↗

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.Semantic proximity Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.Semantic proximity Read ↗

A genomewide association study of citalopram response in major depressive disorder.Semantic proximity Read ↗

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies.Semantic proximity Read ↗

Pharmacogenomics with antidepressants in the STAR*D study.Semantic proximity Read ↗

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.Semantic proximity Read ↗

The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.Semantic proximity Read ↗

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.Semantic proximity Read ↗

Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.